Evaluation of effects of Chinese prescription Kangen-Karyu on diabetes-induced alterations such as oxidative stress and apoptosis in the liver of type 2 diabetic db/db mice

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Park, Chan Hum ^a   Noh, Jeong Sook ^a   Okamoto, Takuya ^b   Park, Jong Cheol ^c   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Iskra Industry Co Ltd   (Japan)

^c Sunchon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; CYCLOOXYGENASE 2; CYTOCHROME C; GLUCOSE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KANGEN KARYU; LEPTIN; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; LIVER DYSFUNCTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION;

EID: 84866972249     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/143489     Document Type: Article

References (47)

1. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007 30 5 1212 1218 2-s2.0-34247605492 10.2337/dc06-2247 (Pubitemid 46684650)
2. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7122 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
3. Li J. M., Shah A. M., ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. Journal of the American Society of Nephrology 2003 14, supplement 3 S221 S226 2-s2.0-0041865372 (Pubitemid 36903929)
4. Newsholme P., Haber E. P., Hirabara S. M., Rebelato E. L. O., Procopio J., Morgan D., Oliveira-Emilio H. C., Carpinelli A. R., Curi R., Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. Journal of Physiology 2007 583 1 9 24 2-s2.0-34547830983 10.1113/jphysiol.2007.135871 (Pubitemid 47244241)
5. Ceylan-Isik A. F., Fliethman R. M., Wold L. E., Ren J., Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Current Diabetes Reviews 2008 4 4 320 328 2-s2.0-59849117369
6. Winslow L. C., Kroll D. J., Herbs as medicines. Archives of Internal Medicine 1998 158 20 2192 2199 2-s2.0-0032501113 10.1001/archinte.158.20.2192 (Pubitemid 28512493)
7. Xu L. N., Yin Z. Z., Ou Y. R., The effect of compositus Guan-Xin NO 2 on myocardial ischaemia and hypoxia in experimental animals. Yao Xue Xue Bao 1979 14 8 461 466 2-s2.0-0018502136
8. Takahashi M., Sugaya K., Kubota K., Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion. Japanese Journal of Pharmacology 1992 60 3 307 310 2-s2.0-0027096568 (Pubitemid 23009069)
9. Gao M., Ikeda K., Noguchi T., Mori K., Yamori Y., Studies on preventive effect of 'Kangenkaryu', Chinese herbal medicine, on stroke in SHR-SP. Journal of Traditional Medicines 2001 18 6 245 250
10. Makino T., Wakushima H., Okamoto T., Okukubo Y., Saito K., Kano Y., Effects of Kangen-karyu on coagulation system and platelet aggregation in mice. Biological & Pharmaceutical Bulletin 2002 25 4 523 525 2-s2.0-0036547862 10.1248/bpb.25.523 (Pubitemid 40036747)
11. 2-induced premature senescence. Journal of Pharmacy and Pharmacology 2008 60 11 1537 1544 2-s2.0-54949136931 10.1211/jpp/60.11.0016
12. Kim H. Y., Okamoto T., Yokozawa T., Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2009 124 2 263 269 2-s2.0-67449123052 10.1016/j.jep.2009.04.032
13. Yamabe N., Kim H. Y., Kang K. S., Zhao Q., Matsumoto K., Yokozawa T., Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db / db mice. Journal of Ethnopharmacology 2010 129 3 299 305 2-s2.0-77953357029 10.1016/j.jep.2010.03.032
14. Noh J. S., Park C. H., Kim H. Y., Zhao Q., Yamabe N., Matsumoto K., Yokozawa T., Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes. Journal of Pharmacy and Pharmacology 2011 63 1 111 119 2-s2.0-78650411008 10.1111/j.2042-7158.2010. 01156.x
15. Okamoto T., Park C. H., Noh J. S., Toriizuka K., Sei Y., Park J. C., Yokozawa T., Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes. Journal of Pharmacy and Pharmacology 2011 63 7 952 959 2-s2.0-79958049192 10.1111/j.2042-7158.2011.01299.x
16. Ali S. F., LeBel C. P., Bondy S. C., Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 1992 13 3 637 648 2-s2.0-0026483404
17. Uchiyama M., Mihara M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 1978 86 1 271 278 2-s2.0-0018069570 (Pubitemid 9050395)
18. Komatsu S., Extraction of nuclear proteins. Methods in Molecular Biology 2007 355 73 77 2-s2.0-39049190420
19. Kakkar R., Mantha S. V., Radhi J., Prasad K., Kalra J., Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clinical Science 1998 94 6 623 632 2-s2.0-0031808543 (Pubitemid 28269062)
20. Kahn S. E., Hull R. L., Utzschneider K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 7121 840 846 2-s2.0-33845881411 10.1038/nature05482 (Pubitemid 46024990)
21. Rossetti L., Giaccari A., Barzilai N., Howard K., Sebel G., Hu M., Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. Journal of Clinical Investigation 1993 92 3 1126 1134 2-s2.0-0027199061 (Pubitemid 23273883)
22. Allison J., Thomas H., Beck D., Brady J. L., Lew A. M., Elefanty A., Kosaka H., Kay T. W., Huang D. C. S., Strasser A., Transgenic overexpression of human Bcl-2 in islet β cells inhibits apoptosis but does not prevent autoimmune destruction. International Immunology 2000 12 1 9 17 2-s2.0-0033957476 (Pubitemid 30045407)
23. Jung U. J., Baek N. I., Chung H. G., Bang M. H., Jeong T. S., Tae Lee K., Kang Y. J., Lee M. K., Kim H. J., Yeo J., Choi M. S., Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ- db / db mice. Clinical Nutrition 2008 27 1 158 167 2-s2.0-38949124062 10.1016/j.clnu.2007.09.009 (Pubitemid 351216895)
24. Davis R. C., Castellani L. W., Hosseini M., Ben-Zeev O., Mao H. Z., Weinstein M. M., Jung D. Y., Jun J. Y., Kim J. K., Lusis A. J., Péterfy M., Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS- db / db mice. Diabetes 2010 59 7 1616 1625 2-s2.0-77954274018 10.2337/db09-0878
25. Lee B. W., Chun S. W., Kim S. H., Lee Y., Kang E. S., Cha B. S., Lee H. C., Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1. Toxicology and Applied Pharmacology 2011 252 1 47 54 2-s2.0-79952617737 10.1016/j.taap.2011.01.018
26. Babior B. M., Lambeth J. D., Nauseef W., The neutrophil NADPH oxidase. Archives of Biochemistry and Biophysics 2002 397 2 342 344 2-s2.0-0037082101 10.1006/abbi.2001.2642 (Pubitemid 34852301)
27. Gao L., Mann G. E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovascular Research 2009 82 1 9 20 2-s2.0-62349116866 10.1093/cvr/cvp031
28. Tong K. I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M., Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Molecular and Cellular Biology 2006 26 8 2887 2900 2-s2.0-33344463325 10.1128/MCB.26.8.2887-2900.2006
29. Anwar A. A., Li F. Y. L., Leake D. S., Ishii T., Mann G. E., Siow R. C. M., Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radical Biology & Medicine 2005 39 2 227 236 2-s2.0-20444456655 10.1016/j.freeradbiomed.2005.03.012 (Pubitemid 40814548)
30. He M., Siow R. C. M., Sugden D., Gao L., Cheng X., Mann G. E., Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 4 277 285 2-s2.0-79952700675 10.1016/j.numecd.2009.12.008
31. Churchman A. T., Anwar A. A., Li F. Y. L., Sato H., Ishii T., Mann G. E., Siow R. C. M., Transforming growth factor- β 1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells. Journal of Cellular and Molecular Medicine 2009 13 8 2282 2292 2-s2.0-72949090169 10.1111/j.1582-4934. 2009.00874.x
32. Siebenlist U., Franzoso G., Brown K., Structure, regulation and function of NF- κ B. Annual Review of Cell Biology 1994 10 405 455 2-s2.0-0028170816
33. García-Mediavilla V., Crespo I., Collado P. S., Esteller A., Sánchez-Campos S., Tuñón M. J., González-Gallego J., The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. European Journal of Pharmacology 2007 557 2-3 221 229 2-s2.0-33846582444 10.1016/j.ejphar.2006.11.014 (Pubitemid 46186282)
34. de Luca C., Olefsky J. M., Inflammation and insulin resistance. FEBS Letters 2008 582 1 97 105 2-s2.0-37549022688 10.1016/j.febslet.2007.11.057 (Pubitemid 50010731)
35. Hsieh P. S., Jin J. S., Chiang C. F., Chan P. C., Chen C. H., Shih K. C., COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity 2009 17 6 1150 1157 2-s2.0-67650484314 10.1038/oby.2008.674
36. Surh Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K., Lee S. S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- κ B activation. Mutation Research 2001 480-481 243 268 2-s2.0-0035451363 (Pubitemid 32744832)
37. Sachse A., Wolf G., Angiotensin II-induced reactive oxygen species and the kidney. Journal of the American Society of Nephrology 2007 18 9 2439 2446 2-s2.0-34548496478 10.1681/ASN.2007020149 (Pubitemid 47378859)
38. Civera M., Urios A., Garcia-Torres M. L., Ortega J., Martinez-Valls J., Cassinello N., Del Olmo J. A., Ferrandez A., Rodrigo J. M., Montoliu C., Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity. Diabetes/Metabolism Research and Reviews 2010 26 3 187 192 2-s2.0-77952351827 10.1002/dmrr.1070
39. Brezniceanu M. L., Liu F., Wei C. C., Chénier I., Godin N., Zhang S. L., Filep J. G., Ingelfinger J. R., Chan J. S. D., Attenuation of interstitial fibrosis and tubular apoptosis in db / db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008 57 2 451 459 2-s2.0-40749161602 10.2337/db07-0013
40. Crompton M., Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Current Opinion in Cell Biology 2000 12 4 414 419 2-s2.0-0033936787 10.1016/S0955-0674(00)00110-1 (Pubitemid 30453590)
41. Garcia-Ruiz C., Fernández-Checa J. C., Redox regulation of hepatocyte apoptosis. Journal of Gastroenterology and Hepatology 2007 22, supplement 1 S38 S42 2-s2.0-34249827611 10.1111/j.1440-1746.2006.04644.x (Pubitemid 46848988)
42. Behrens A., Sibilia M., Wagner E. F., Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nature Genetics 1999 21 3 326 329 2-s2.0-0032979438 10.1038/6854 (Pubitemid 29124945)
43. Kriehuber E., Bauer W., Charbonnier A. S., Winter D., Amatschek S., Tamandl D., Schweifer N., Stingl G., Maurer D., Balance between NF- κ B and JNK/AP-1 activity controls dendritic cell life and death. Blood 2005 106 1 175 183 2-s2.0-22044455860 10.1182/blood-2004-08-3072 (Pubitemid 40967190)
44. Czaja M. J., The future of GI and liver research: editorial perspectives III. JNK/AP-1 regulation of hepatocyte death. American Journal of Physiology: Gastrointestinal and Liver Physiology 2003 284 6 G875 G879 2-s2.0-0037910211 (Pubitemid 36597328)
45. Hase K., Kasimu R., Basnet P., Kadota S., Namba T., Preventive effect of lithospermate B from Salvia miltiorrhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Planta Medica 1997 63 1 22 26 2-s2.0-0031047797 10.1055/s-2006-957596 (Pubitemid 27112432)
46. Mueller M., Lukas B., Novak J., Simoncini T., Genazzani A. R., Jungbauer A., Oregano: a source for peroxisome proliferator-activated receptor γ antagonists. Journal of Agricultural and Food Chemistry 2008 56 24 11621 11630 2-s2.0-58849083337 10.1021/jf802298w
47. Yang H. O., Ko W. K., Kim J. Y., Ro H. S., Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia 2004 75 1 45 49 2-s2.0-0346993519 10.1016/j.fitote.2003.08.016 (Pubitemid 38010403)